ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,239, issued on Dec. 9, was assigned to Secretary of State for Health and Social Care (London) and MicroPharm Ltd. (Carmarthenshire, Great Britain).
"Clostridium difficile antigens" was invented by Clifford Shone (Salisbury, Great Britain), April Roberts (Salisbury, Great Britain), Helen Ahern (Salisbury, Great Britain), Michael Maynard-Smith (Salisbury, Great Britain) and John Landon (Newcastle Emlyn, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to recombinant Clostridium difficile antigens based on a fusion protein that consists of or comprises a first amino acid sequence and a second amino acid sequen...